Cargando…

EMA Review of Panobinostat (Farydak) for the Treatment of Adult Patients with Relapsed and/or Refractory Multiple Myeloma

Detalles Bibliográficos
Autores principales: Tzogani, Kyriaki, Hennik, Paula Van, Walsh, Ita, De Graeff, Pieter, Folin, Annika, Sjöberg, Jan, Salmonson, Tomas, Bergh, Jonas, Laane, Edward, Ludwig, Heinz, Gisselbrecht, Christian, Pignatti, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AlphaMed Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058342/
https://www.ncbi.nlm.nih.gov/pubmed/30037941
http://dx.doi.org/10.1634/theoncologist.2017-0301erratum
_version_ 1783341673593438208
author Tzogani, Kyriaki
Hennik, Paula Van
Walsh, Ita
De Graeff, Pieter
Folin, Annika
Sjöberg, Jan
Salmonson, Tomas
Bergh, Jonas
Laane, Edward
Ludwig, Heinz
Gisselbrecht, Christian
Pignatti, Francesco
author_facet Tzogani, Kyriaki
Hennik, Paula Van
Walsh, Ita
De Graeff, Pieter
Folin, Annika
Sjöberg, Jan
Salmonson, Tomas
Bergh, Jonas
Laane, Edward
Ludwig, Heinz
Gisselbrecht, Christian
Pignatti, Francesco
author_sort Tzogani, Kyriaki
collection PubMed
description
format Online
Article
Text
id pubmed-6058342
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher AlphaMed Press
record_format MEDLINE/PubMed
spelling pubmed-60583422018-07-25 EMA Review of Panobinostat (Farydak) for the Treatment of Adult Patients with Relapsed and/or Refractory Multiple Myeloma Tzogani, Kyriaki Hennik, Paula Van Walsh, Ita De Graeff, Pieter Folin, Annika Sjöberg, Jan Salmonson, Tomas Bergh, Jonas Laane, Edward Ludwig, Heinz Gisselbrecht, Christian Pignatti, Francesco Oncologist Erratum AlphaMed Press 2018-07-23 2018-07 /pmc/articles/PMC6058342/ /pubmed/30037941 http://dx.doi.org/10.1634/theoncologist.2017-0301erratum Text en © AlphaMed Press 2018
spellingShingle Erratum
Tzogani, Kyriaki
Hennik, Paula Van
Walsh, Ita
De Graeff, Pieter
Folin, Annika
Sjöberg, Jan
Salmonson, Tomas
Bergh, Jonas
Laane, Edward
Ludwig, Heinz
Gisselbrecht, Christian
Pignatti, Francesco
EMA Review of Panobinostat (Farydak) for the Treatment of Adult Patients with Relapsed and/or Refractory Multiple Myeloma
title EMA Review of Panobinostat (Farydak) for the Treatment of Adult Patients with Relapsed and/or Refractory Multiple Myeloma
title_full EMA Review of Panobinostat (Farydak) for the Treatment of Adult Patients with Relapsed and/or Refractory Multiple Myeloma
title_fullStr EMA Review of Panobinostat (Farydak) for the Treatment of Adult Patients with Relapsed and/or Refractory Multiple Myeloma
title_full_unstemmed EMA Review of Panobinostat (Farydak) for the Treatment of Adult Patients with Relapsed and/or Refractory Multiple Myeloma
title_short EMA Review of Panobinostat (Farydak) for the Treatment of Adult Patients with Relapsed and/or Refractory Multiple Myeloma
title_sort ema review of panobinostat (farydak) for the treatment of adult patients with relapsed and/or refractory multiple myeloma
topic Erratum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058342/
https://www.ncbi.nlm.nih.gov/pubmed/30037941
http://dx.doi.org/10.1634/theoncologist.2017-0301erratum
work_keys_str_mv AT tzoganikyriaki emareviewofpanobinostatfarydakforthetreatmentofadultpatientswithrelapsedandorrefractorymultiplemyeloma
AT hennikpaulavan emareviewofpanobinostatfarydakforthetreatmentofadultpatientswithrelapsedandorrefractorymultiplemyeloma
AT walshita emareviewofpanobinostatfarydakforthetreatmentofadultpatientswithrelapsedandorrefractorymultiplemyeloma
AT degraeffpieter emareviewofpanobinostatfarydakforthetreatmentofadultpatientswithrelapsedandorrefractorymultiplemyeloma
AT folinannika emareviewofpanobinostatfarydakforthetreatmentofadultpatientswithrelapsedandorrefractorymultiplemyeloma
AT sjobergjan emareviewofpanobinostatfarydakforthetreatmentofadultpatientswithrelapsedandorrefractorymultiplemyeloma
AT salmonsontomas emareviewofpanobinostatfarydakforthetreatmentofadultpatientswithrelapsedandorrefractorymultiplemyeloma
AT berghjonas emareviewofpanobinostatfarydakforthetreatmentofadultpatientswithrelapsedandorrefractorymultiplemyeloma
AT laaneedward emareviewofpanobinostatfarydakforthetreatmentofadultpatientswithrelapsedandorrefractorymultiplemyeloma
AT ludwigheinz emareviewofpanobinostatfarydakforthetreatmentofadultpatientswithrelapsedandorrefractorymultiplemyeloma
AT gisselbrechtchristian emareviewofpanobinostatfarydakforthetreatmentofadultpatientswithrelapsedandorrefractorymultiplemyeloma
AT pignattifrancesco emareviewofpanobinostatfarydakforthetreatmentofadultpatientswithrelapsedandorrefractorymultiplemyeloma